Osaka, Japan

Mitsuo Numata


Average Co-Inventor Count = 3.5

ph-index = 6

Forward Citations = 144(Granted Patents)


Location History:

  • Takatsuki, JA (1976 - 1978)
  • Osaka, JA (1977 - 1978)
  • Osaka, JP (1979 - 1989)
  • Takatsuki, JP (1980 - 1992)

Company Filing History:


Years Active: 1976-1992

Loading Chart...
21 patents (USPTO):Explore Patents

Title: Innovations of Mitsuo Numata: A Pioneer in Antibiotic Development

Introduction

Mitsuo Numata, an esteemed inventor based in Osaka, Japan, has made significant contributions to the field of antibiotic research and development. With a remarkable portfolio of 21 patents, his work has focused on cephalosporin derivatives, advancing the efficacy and delivery of pharmaceutical compounds that play a crucial role in combating bacterial infections.

Latest Patents

Numata’s most recent patents include an innovative class of cephalosporin ester derivatives. These compounds, characterized by specific molecular formulas, exhibit improved absorbability, allowing for effective oral application as antibiotics. Additionally, he has developed a series of cephalosporin derivatives, notably 2-(syn)-hydroxyimino-acetamide derivatives, which are positioned as valuable antibacterial agents. These advancements underscore his commitment to enhancing pharmaceutical compositions and processes for their production.

Career Highlights

Throughout his career, Mitsuo Numata has been associated with leading pharmaceutical companies, including Takeda Chemical Industries, Inc. and Tatsuo Chemical Industries, Ltd. His expertise and innovative approach have positioned him as a key player in the development of new antibiotic solutions, contributing significantly to the scientific community.

Collaborations

Numata has collaborated with prominent figures such as Masayoshi Yamaoka and Isao Minamida. These partnerships have facilitated the exchange of ideas and have been instrumental in driving forward innovative projects within the realm of antibiotic research.

Conclusion

Mitsuo Numata's contributions to the field of pharmaceuticals, particularly in antibiotic development, are profound. His extensive patent portfolio and collaborative efforts exemplify the spirit of innovation that drives progress in the medical community. As he continues to explore new avenues in research, his work remains a cornerstone for future advancements in treatment options for bacterial infections.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…